Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach | MicrobiomeTrials← Back to trialsNCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-03-31Est. Completion: 2026-10-31
Enrollment target: 143 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Primary Sclerosing Cholangitis
This study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis…
Lancaster, United StatesEst. completion Sep 23, 2031
Primary Sclerosing CholangitisLiver DiseasesCholangitis, Sclerosing
Primary sclerosing cholangitis (PSC) is a rare liver disease that damages the liver's bile ducts. Bile ducts are tiny tu…
Los Angeles, United StatesEst. completion May 31, 2029